sante61 %Grifols' AMBAR program shows a 61% reduction in disease progression

Grifols slows disease progression with plasma exchange

Grifols' AMBAR program shows a 61% reduction in disease progression.

Published 1h1 sourceNotable

≈ 15sSpeed

The fact

Real-world clinical data confirms the effectiveness of therapeutic plasma exchange.

This breakthrough could provide a new option for affected patients.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on September 21, 2026